BPIQ Blog

What to do Now with FGEN After FDA Meltdown

Summary: FGEN stock was crushed last week on strong votes against Roxadustat in both DD and NDD by FDA AdComm Big-Mover event In battle...

Jul 18, 20216 min read

6/21/21 Update. As was predicted by Dr. Vacchiano in his articles on BPIQ.com, the Supreme Court DENIED AMRN's Petition for Cert. This...

Jun 13, 20214 min read

Our platform helps you uncover your next biotech investment opportunity